Related Articles
Targeted therapy in HER2‑positive breast cancer (Review)
Targeted therapy for gastric cancer: Current status and future directions (Review)
Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation
Dose adjustment for tyrosine kinase inhibitors in non‑small cell lung cancer patients with hepatic or renal function impairment (Review)
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy